Applications of technology in the assessment and treatment of cannabis use disorder

Abstract

Cannabis use and Cannabis Use Disorder (CUD) have been increasing. There are no FDA approved medications and evidence-based psychotherapy is limited by insufficient providers, serving very few patients effectively. The lack of resources for prevention and treatment of CUD has resulted in a significant gap between the need for services and access to treatment. The creation of a scalable system to prevent, screen, refer and provide treatment for a chronic, relapsing diagnosis like CUD could be achieved through the application of technology. Many studies have utilized ecological momentary assessments (EMA) in treatment seeking and non-treatment seeking cannabis users. EMA allows for repeated, intensive, longitudinal data collection in vivo. EMA has been studied in cannabis use and its association with affect, craving, withdrawal, other substances, impulsivity, and interpersonal behaviors. EMA has the potential to serve as a valuable monitoring tool in prevention, screening, and treatment for CUD. Research has also focused on the development of internet and application-based treatments for CUD, including a currently available prescription digital therapeutic. Treatment options have expanded to more broadly incorporate telehealth as an option for CUD treatment with broad acceptance and change in regulation following the COVID-19 pandemic. While technology has limitations, including cost, privacy concerns, and issues with engagement, it will be a necessary medium to meet societal health needs as a consequence of an ever-changing cannabis regulatory landscape. Future work should focus on improving existing platforms while ethically incorporating other functions (e.g., sensors) to optimize a public and clinical health approach to CUD.

Marijuana use disorder among adults with functional disabilities—A US population‐based cross‐sectional study

“…A Cochrane systematic review of psychosocial interventions for marijuana use disorder determined that the use of cognitive‐behavioral therapy, motivational enhancement therapy, and a combination of the two therapies were consistently the most effective treatments for marijuana use disorder 29 . The mode of delivery and available treatments for marijuana use disorder are currently expanding to include more digital options through internet applications and telehealth 30 . These treatments may improve access and inclusivity for PWD, particularly those who have impaired mobility or experience increased mental distress regarding visiting a medical practitioner in person.…”

“…29 The mode of delivery and available treatments for marijuana use disorder are currently expanding to include more digital options through internet applications and telehealth. 30 These treatments may improve access and inclusivity for PWD, particularly those who have impaired mobility or experience increased mental distress regarding visiting a medical practitioner in person.…”

A Comprehensive Review on Biofilms in Otorhinolaryngology: Understanding the Pathogenesis, Diagnosis, and Treatment Strategies

“…The projected increase in the role of data scientists in clinical trials is set to coincide with the emergence of new technologies and the introduction of a novel three-phase registration model for therapies. This model is envisioned to encompass quality evaluation, safety assessment, and tailored administration options, potentially streamlining drug development processes to be more efficient and patient-centered [ 63 ]. Future therapies for cystic fibrosis are exploring a spectrum of approaches aimed at addressing the condition comprehensively.…”

Digital Therapeutics as a New Therapeutic Modality: A Review from the Perspective of Clinical Pharmacology

“…From the initial idea of digitalizing CBT, DTx have evolved and continue to expand the range of embedded digital interventions and targeted areas. In Table 1 we compiled a nonexhaustive list of references across a variety of indications where DTx are currently developed, used or foreseen to play a key role for patients 2–41 . This illustrates why their development is associated with significant promise, in particular for tackling the continuously growing burden of chronic diseases 42 …”